These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 11810599

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Azithromycin prophylaxis for Mycobacterium avium complex during the era of highly active antiretroviral therapy: evaluation of a provincial program.
    Phillips P, Chan K, Hogg R, Bessuille E, Black W, Talbot J, O'Shaughnessy M, Montaner J.
    Clin Infect Dis; 2002 Feb 01; 34(3):371-8. PubMed ID: 11774085
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Discontinuation of primary prophylaxis against Mycobacterium avium complex infection in HIV-infected persons receiving antiretroviral therapy: observations from a large national cohort in the United States, 1992-2002.
    Brooks JT, Song R, Hanson DL, Wolfe M, Swerdlow DL, Adult and Adolescent Spectrum of Disease Working Group.
    Clin Infect Dis; 2005 Aug 15; 41(4):549-53. PubMed ID: 16028167
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E, Coureau G, Guedj J, Blanco P, Pellegrin I, Commenges D, Dabis F, Moreau JF, Pellegrin JL, Thiébaut R, ANRS Co3 Aquitaine Cohort.
    Antivir Ther; 2006 Aug 15; 11(3):343-50. PubMed ID: 16759051
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mycobacterium avium complex infection in HIV/AIDS patients.
    Corti M, Palmero D.
    Expert Rev Anti Infect Ther; 2008 Jun 15; 6(3):351-63. PubMed ID: 18588499
    [Abstract] [Full Text] [Related]

  • 9. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B, Mocroft A, Reiss P, Furrer H, Kirk O, Bickel M, Uberti-Foppa C, Pradier C, D'Arminio Monforte A, Schneider MM, Lundgren JD, Eight European Study Groups.
    N Engl J Med; 2001 Jan 18; 344(3):168-74. PubMed ID: 11188837
    [Abstract] [Full Text] [Related]

  • 10. Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy.
    Jubault V, Pacanowski J, Rabian C, Viard JP.
    Ann Med Interne (Paris); 2000 May 18; 151(3):163-8. PubMed ID: 10896967
    [Abstract] [Full Text] [Related]

  • 11. Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection.
    Liao CH, Chen MY, Hsieh SM, Sheng WH, Hung CC, Chang SC.
    J Microbiol Immunol Infect; 2004 Feb 18; 37(1):50-6. PubMed ID: 15060688
    [Abstract] [Full Text] [Related]

  • 12. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
    Jung Y, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Kim HB, Park SW, Kim NJ, Oh MD.
    Int J STD AIDS; 2017 Dec 18; 28(14):1426-1432. PubMed ID: 28592210
    [Abstract] [Full Text] [Related]

  • 13. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B.
    J Infect Dis; 2000 May 18; 181(5):1635-42. PubMed ID: 10823763
    [Abstract] [Full Text] [Related]

  • 14. Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy.
    Gill J, Moyle G, Nelson M.
    AIDS; 1998 Apr 16; 12(6):680. PubMed ID: 9583614
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
    Phillips P, Bonner S, Gataric N, Bai T, Wilcox P, Hogg R, O'Shaughnessy M, Montaner J.
    Clin Infect Dis; 2005 Nov 15; 41(10):1483-97. PubMed ID: 16231262
    [Abstract] [Full Text] [Related]

  • 17. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
    López-Palomo C, Martín-Zamorano M, Benítez E, Fernández-Gutiérrez C, Guerrero F, Rodríguez-Iglesias M, Girón-González JA.
    J Med Virol; 2004 Apr 15; 72(4):517-24. PubMed ID: 14981752
    [Abstract] [Full Text] [Related]

  • 18. [Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].
    Schneider MM, Reiss P, Borleffs JC, Rozenberg-Arska M, Hoepelman IM.
    Ned Tijdschr Geneeskd; 1997 Jan 11; 141(2):80-3. PubMed ID: 9036351
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC.
    N Engl J Med; 1996 Aug 08; 335(6):384-91. PubMed ID: 8663871
    [Abstract] [Full Text] [Related]

  • 20. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun 08; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.